H.R.1 makes key changes to Medicare’s drug price negotiation program, specifically expanding exemptions for orphan drugs those intended to treat rare diseases.
Share this post
Quick Policy Note - 📝 Orphan Cures…
Share this post
H.R.1 makes key changes to Medicare’s drug price negotiation program, specifically expanding exemptions for orphan drugs those intended to treat rare diseases.